,

지방대학의 융합교육의 미래

,

Development of Immunotherapeutic technology based on exosomes derived from engineered T cells

,

IL2 induces anticancer immune response by regulating sEV secretion and PD-La espression in cancer cells

,

FDA-approved drugs targeting an ETA elicit antitumor immune response along with immune chcekpoint therapy by inhibiting exosomal PD-L1

,

Macitentan attenuate extracellular vesicle PD-L1 mediated immunisuppression